Virtual Medicinal Product (VMP)
-
Fusidic acid 250mg/5ml oral suspension
Name Details
|
Current Name
Fusidic acid 250mg/5ml oral suspension
|
Start Date
27-02-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J01XC01
| BNF |
|
Current BNF
05010700
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
05010700
|
Start Date
03-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 41950611000001109 |
09-06-2023 |
|
| 324317000 |
27-02-2003 |
08-06-2023 |
VMP Ingredients
VMP ingredients table
| Fusidic acid |
Based on Ingredient Substance |
|
50 mg |
1 ml |
Name
Fusidic acid
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Fusidic acid
-
VMP
(Current) Fusidic acid 250mg/5ml oral suspension
Virtual Medicinal Product Pack (VMPP) Information